SPAC Overview
Timeline Progress
About
JATT II Acquisition Corp. is a blank-check company seeking a target for an initial business combination. It intends to focus on healthcare and healthcare-related businesses, especially biotechnology and broader life sciences, including companies using data-driven approaches in therapeutic discovery and development.
Investment Focus
Healthcare, Biopharmaceuticals
The terms and the filing trail behind JATT II ACQUISITION CORP
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
Led by Chairman and CEO Dr. Someit Sidhu, a life-sciences entrepreneur and investor with prior SPAC and biotech operating experience, and CFO Nicholas Fernandez, an experienced finance and operations executive. Director nominees contribute investment-banking, biotechnology investing, venture-capital and life-sciences expertise.